ZA200807943B - Antibiotic compositions of modified release and process of production thereof - Google Patents

Antibiotic compositions of modified release and process of production thereof

Info

Publication number
ZA200807943B
ZA200807943B ZA200807943A ZA200807943A ZA200807943B ZA 200807943 B ZA200807943 B ZA 200807943B ZA 200807943 A ZA200807943 A ZA 200807943A ZA 200807943 A ZA200807943 A ZA 200807943A ZA 200807943 B ZA200807943 B ZA 200807943B
Authority
ZA
South Africa
Prior art keywords
production
modified release
antibiotic compositions
antibiotic
compositions
Prior art date
Application number
ZA200807943A
Other languages
English (en)
Inventor
Jain Rajesh
Jindal Kour Chand
Talwar Munish
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of ZA200807943B publication Critical patent/ZA200807943B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/424Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200807943A 2006-03-24 2007-03-07 Antibiotic compositions of modified release and process of production thereof ZA200807943B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN824DE2006 2006-03-24

Publications (1)

Publication Number Publication Date
ZA200807943B true ZA200807943B (en) 2009-11-25

Family

ID=38540834

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200807943A ZA200807943B (en) 2006-03-24 2007-03-07 Antibiotic compositions of modified release and process of production thereof

Country Status (16)

Country Link
US (1) US20090111788A1 (zh)
EP (1) EP2001465A1 (zh)
JP (1) JP2009530367A (zh)
KR (1) KR20090006123A (zh)
CN (1) CN101410109A (zh)
AU (1) AU2007230546A1 (zh)
BR (1) BRPI0709179A2 (zh)
CA (1) CA2644911A1 (zh)
CR (1) CR10388A (zh)
EA (1) EA200870368A1 (zh)
MA (1) MA30335B1 (zh)
MX (1) MX2008012260A (zh)
RS (1) RS20080430A (zh)
TN (1) TNSN08348A1 (zh)
WO (1) WO2007110875A1 (zh)
ZA (1) ZA200807943B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009055038A1 (en) * 2007-10-26 2009-04-30 Rexahn Pharmaceuticals, Inc. Pharmaceutical formulation of clavulanic acid
US20090148532A1 (en) * 2007-12-06 2009-06-11 Venkatesh Gopi M Preparation of controlled release skeletal muscle relaxant dosage forms
JP4706785B2 (ja) * 2008-09-30 2011-06-22 アステラス製薬株式会社 経口投与用粒子状医薬組成物
BRPI1013901A2 (pt) * 2009-04-29 2019-09-24 Rexahn Pharmaceuticals Inc formulação de clavulanato para neuroproteção e tratamento de distúrbios neurodegenerativos
US20130131033A1 (en) * 2010-01-13 2013-05-23 Toyochem Laboratories Pharmaceutical composition for treatment of respiratory tract infections
EP2575777A1 (en) * 2010-06-03 2013-04-10 Mahmut Bilgic Formulation comprising cefpodoxime proxetil and clavulanic acid
CN102861015B (zh) * 2011-07-05 2015-07-08 北京乐维生物技术有限公司 一种稳定的阿莫西林克拉维酸钾缓释制剂及其制备工艺
WO2014033077A1 (en) 2012-08-28 2014-03-06 Dsm Sinochem Pharmaceuticals Netherlands B.V. Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at| least one of them is in the form of mini-tablets
US9254261B2 (en) * 2014-03-03 2016-02-09 Sandoz Ag Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid
US11813361B2 (en) 2014-04-04 2023-11-14 Pharmaquest International Center, Llp Disintegrating monolithic modified release tablets containing quadri-layer extended release granules
US10335374B2 (en) * 2014-12-04 2019-07-02 University System of Georgia, Valdosta State University Tablet composition for anti-tuberculosis antibiotics
WO2016134121A1 (en) * 2015-02-20 2016-08-25 Cytec Industries Inc. Dialkyl sulfosuccinate compositions, method of making, and method of use
JP7370124B2 (ja) * 2018-11-09 2023-10-27 日本化薬株式会社 エルロチニブを有効成分とする医薬錠剤
JP7370125B2 (ja) * 2018-11-09 2023-10-27 日本化薬株式会社 エルロチニブを有効成分とする医薬錠剤
CN113116860B (zh) * 2021-04-22 2022-11-25 海南通用三洋药业有限公司 一种阿莫西林胶囊及其制备方法
CN113398069A (zh) * 2021-07-10 2021-09-17 四川成康动物药业有限公司 兽用阿莫西林与磺胺嘧啶钠混悬注射液及制备方法和装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201930D0 (sv) * 1992-06-24 1992-06-24 Astra Ab Gastric antibacterial treatment
WO2002030392A2 (en) * 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles

Also Published As

Publication number Publication date
CR10388A (es) 2009-01-19
MX2008012260A (es) 2008-10-07
MA30335B1 (fr) 2009-04-01
JP2009530367A (ja) 2009-08-27
BRPI0709179A2 (pt) 2011-06-28
TNSN08348A1 (en) 2009-12-29
CN101410109A (zh) 2009-04-15
EA200870368A1 (ru) 2009-04-28
US20090111788A1 (en) 2009-04-30
RS20080430A (en) 2009-05-06
AU2007230546A1 (en) 2007-10-04
CA2644911A1 (en) 2007-10-04
WO2007110875A1 (en) 2007-10-04
EP2001465A1 (en) 2008-12-17
KR20090006123A (ko) 2009-01-14

Similar Documents

Publication Publication Date Title
ZA200807943B (en) Antibiotic compositions of modified release and process of production thereof
EP2021445A4 (en) PROCESS COMPOSITIONS AND PREPARATION OF ACYL-ALKYL-ISETHIONATE COMPOSITIONS
EP2041266A4 (en) COMPOSITIONS AND METHOD FOR BUTANEAN MANUFACTURE
GB2451409B (en) Production of band-driven packages and their components
ZA200903581B (en) Dry-scrubbing media compositions and methods of production and use
EP2221346A4 (en) MOLDING COMPOSITION CONTAINING GLASS AND METHOD FOR PRODUCING THE SAME
EP2206429A4 (en) ANTIBIOTIC COMPOSITION AND MANUFACTURING METHOD THEREFOR
ZA200806799B (en) Novel pyrone-indole derivatives and process for their preparation
IL186712A0 (en) New process of making biomaterials
ZA200806434B (en) Calcium-enrichment compositions and methods for production thereof
SG2014012785A (en) Process compositions and production of acyl alkylisethionate compositions
GB0606554D0 (en) Novel compounds and methods for their production
EP2315802A4 (en) AZIUM COMPOSITIONS AND METHOD FOR THEIR PREPARATION AND USE
GB0602557D0 (en) Production of cabergoline and novel polymorphic form thereof
GB0607488D0 (en) Composition and process
GB0605004D0 (en) Composition and process
GB0606542D0 (en) Novel compounds and methods for their production
GB2469959B (en) Dioctatin derivatives and production process thereof
IL195845A0 (en) Methods of making and using rubidium-81-containing compositions
GB0607493D0 (en) Composition and process
PL383914A1 (pl) Kompozycja farmaceutyczna i sposób wytwarzania kompozycji farmaceutycznej
GB0709701D0 (en) Composition and process for its production
GB2457188B (en) Production of band-driven packages and their components
GB0608545D0 (en) Process and compositions
GB0603947D0 (en) Cementitious composites & methods of their manufacture